E2603 – A Double-blind, Randomized, Placebo-Controlled Phase III Trial of Carboplatin, Paclitaxel and Sorafenib versus Carboplatin, Paclitaxel and Placebo in Patients with Unresectable Locally Advanced or Stage IV Melanoma

Physician and Research Staff Educational Materials:

  • None available

Patient Educational Materials:

  • Patient FAQs: frequently asked questions from patients about treatment, eligibility criteria, and potential enrollment issues, with answers in lay language.

Additional Information at ClinicalTrials.gov:

NCT00110019